Comparing two cryoablation techniques for treating atrial fibrillation
Official title: Wide-Antral Pulmonary Vein Isolation in Patients Undergoing Atrial Fibrillation Ablation with a Single-shot Technique: the WIDER-PVI Trial
Run by Hospital Universitario 12 de Octubre · NCT06698159 · Data updated 2026-11-12
This study is testing whether a larger cryoablation technique can help people with atrial fibrillation have fewer heart rhythm problems after treatment compared to a smaller technique.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 440 (estimated) |
| Sponsor | Hospital Universitario 12 de Octubre Academic / other |
| Locations | 17 sites (Pozzilli, Isernia and 16 other locations) |
| Status | Recruiting |
| Started | November 1, 2024 |
| Main results expected | May 1, 2026 |
| Study ends | June 30, 2027 |
| Registry record updated | November 20, 2024 |
| Trial ID | NCT06698159 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old with a recent diagnosis of paroxysmal or persistent atrial fibrillation who require pulmonary vein isolation.
✕Probably not a fit
Patients with severe left atrial dilatation, previous ablation procedures, or significant comorbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The WIDER-PVI study is a multicenter randomized clinical trial designed to compare the efficacy of two cryoablation techniques for pulmonary vein isolation in patients with paroxysmal or persistent atrial fibrillation. Participants will undergo either antral isolation using a 28 mm cryoballoon or extended antral isolation using a 31 mm cryoballoon. The primary objective is to determine if the extended antral isolation technique results in lower recurrence rates of atrial tachyarrhythmias at one year follow-up. This study aims to provide insights into the effectiveness of newer, larger cryoablation devices in improving patient outcomes.
Why it matters
Potential benefit: If successful, this study could lead to more effective treatment options for patients with atrial fibrillation, potentially reducing the recurrence of arrhythmias.
How similar studies have gone: Previous studies have shown promising results with cryoablation techniques, but this specific comparison of antral versus extended antral isolation is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age over 18 years old. * Previous diagnosis of paroxysmal or persistent atrial fibrillation less than 2 years after diagnosis. * Clinical indication to undergo a pulmonary vein isolation procedure using balloon cryoablation. Exclusion Criteria: * Severe left atrial dilatation (indexed volume \>48 ml/m2 or area \>40 cm2 or indexed diameter \>3.0 cm/m2). * Previous endocardial or surgical ablation of atrial fibrillation. * Severe frailty (Clinical Frailty Scale score 7 or higher) or life expectancy less than 1 year. * Inability to understand or give informed consent. * Performance of other left atrial ablations in addition to pulmonary veins. * Need to use another catheter in addition to the cryoablation catheter to complete pulmonary vein isolation. * Contraindication to anticoagulation or intolerance to heparin. * Presence of intra-atrial thrombus. * Reversible cause of atrial fibrillation. * Severe mitral or aortic valve disease. * Congenital heart disease. * Pregnancy or the prospect of pregnancy in the next 12 months.
Where it's running
-
Hospital Universitario 12 de Octubre
Madrid, Spain Recruiting -
IRCCS Neuromed Mediterranean Neurological Institute
Pozzilli, Isernia, Italy Not yet recruiting -
Casa di cura Villa dei Fiori
Acerra, Napoli, Italy Not yet recruiting -
Poliambulanza Institute Hospital Foundation
Brescia, Italy Not yet recruiting -
Ospedale Santa Maria Goretti
Latina, Italy Not yet recruiting -
Clinica San Michele
Maddaloni, Italy Not yet recruiting
Show 11 more locations
-
Fondazione IRCCS San Gerardo dei Tintori
Monza, Italy Not yet recruiting -
Pellegrini Hospital
Naples, Italy Not yet recruiting -
Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova
Padova, Italy Not yet recruiting -
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, University "Cattolica del Sacro Cuore"
Rome, Italy Not yet recruiting -
S. Pietro Fatebenefratelli Hospital
Rome, Italy Not yet recruiting -
HU Basurto
Bilbao, Spain Not yet recruiting -
HU Virgen de las Nieves
Granada, Spain Not yet recruiting -
HU Juan Ramón Jiménez
Huelva, Spain Not yet recruiting -
HU Ramón y Cajal
Madrid, Spain Not yet recruiting -
HU Virgen de la Victoria
Málaga, Spain Not yet recruiting -
HU Virgen Macarena
Seville, Spain Not yet recruiting
Study contacts
- Study coordinator: Daniel Rodríguez Muñoz, MD PhD
- Email: daniel.rodriguez.mnz@gmail.com
- Phone: 659385591
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Left-atrial Fibrosis in Persistent Atrial Fibrillation and Its Comorbidities
This study tests how comorbid conditions like sleep apnea and primary aldosteronism relate to left-atrial fibrosis and AF recurrence in patients undergoing ablation.
-
Dual Energy ablation with SmartTouch SF catheter in persistent atrial fibrillation
This study tests a pulsed field and radiofrequency ablation system to treat persistent atrial fibrillation in adults who have not responded well to prior medications.
-
Identifying AF patients who may need more than standard ablation using Volta AF-Xplorer II
This trial tests whether AI-identified dispersion areas during AF ablation can predict recurrence after a standard pulmonary vein isolation in patients with persistent AF.
-
4D intracardiac echocardiography to guide left atrial appendage occlusion procedures
A new 4D ICE catheter is being tested alongside standard imaging to see if it can safely guide left atrial appendage occlusion procedures for adults with atrial fibrillation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.